Opsumit 10MG-QTY 2 @ 6,426.78
Ended Awarded Last action
- Contract number
- 15B50526F00000106
- Awardee
-
Actelion Pharmaceuticals US, Inc. UEI H5BMHLMMNA28
- Awarding agency
-
Federal Medical Center Carswell
Correctional Facilities, Department of Justice
- Obligated
- $12,854
Award facts
- Contract value 100% obligated
- $12,853.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- Q517 Pharmacy Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Titusville, Hopewell Township, NJ 08560, USA
Award details come from SAM.gov/FPDS.
About this award
Federal Medical Center Carswell issued a delivery order to Actelion Pharmaceuticals US, Inc. on March 1, 2026, for $12,853.56 to procure Opsumit 10mg tablets (quantity 2 units at $6,426.78 each) under a firm fixed-price arrangement. The ultimate completion date is March 31, 2026. Opsumit is a specialized pharmaceutical treatment for pulmonary arterial hypertension that Actelion supplies to federal healthcare facilities, including correctional institutions and veterans' medical centers. This delivery order does not utilize a set-aside designation and represents a routine procurement under the vendor's existing contract vehicles.
This award is issued under Actelion's Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and Drugs, valued at $219.1 million and effective through July 31, 2029, which enables federal agencies to procure the company's specialized pharmaceutical portfolio without conducting individual competitive solicitations. The parent contract is funded by the Department of Veterans Affairs through Veterans Integrated Service Network 12 and supports the Department of Justice's Federal Bureau of Prisons operations, including Federal Medical Center Carswell in Hopewell Township, New Jersey. Actelion is a large pharmaceutical manufacturer without small business designations that maintains a substantial federal presence through multiple indefinite delivery vehicles supporting rare disease medications across federal healthcare institutions nationwide.
Quick answers
Who was awarded contract 15B50526F00000106?
15B50526F00000106 was awarded to Actelion Pharmaceuticals US, Inc. by Federal Medical Center Carswell (Correctional Facilities) on March 1, 2026.
How much is contract 15B50526F00000106 worth?
The government has obligated $12,854 on 15B50526F00000106.
Is contract 15B50526F00000106 an order under another contract?
Yes. 15B50526F00000106 is a delivery order under 36F79724D0159, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 15B50526F00000106 competed?
The extent of competition for 15B50526F00000106 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award